Cargando…

Universal Germline Genetic Testing for Hereditary Cancer Syndromes in Patients With Solid Tumor Cancer

Detalles Bibliográficos
Autores principales:	Esplin, Edward D., Nielsen, Sarah M., Bristow, Sara L., Garber, Judy E., Hampel, Heather, Rana, Huma Q., Samadder, N. Jewel, Shore, Neal D., Nussbaum, Robert L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2022
Materias:	COMMENTARIES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489188/ https://www.ncbi.nlm.nih.gov/pubmed/36108258 http://dx.doi.org/10.1200/PO.21.00516

Ejemplares similares

Rate of Pathogenic Germline Variants in Patients With Lung Cancer
por: Sorscher, Steven, et al.
Publicado: (2023)

Germline Cancer Susceptibility Gene Testing in Unselected Patients with Hepatobiliary Cancers: A Multi-Center Prospective Study
por: Uson Junior, Pedro LS, et al.
Publicado: (2022)

Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing Study
por: Uson, Pedro L. S., et al.
Publicado: (2021)

Germline Pathogenic Variant Prevalence Among Latin American and US Hispanic Individuals Undergoing Testing for Hereditary Breast and Ovarian Cancer: A Cross-Sectional Study
por: Ossa Gomez, Carlos Andrés, et al.
Publicado: (2022)

Germline Cancer Testing in Unselected Patients with Gastric and Esophageal Cancers: A Multi-center Prospective Study
por: Uson, P. L. S., et al.
Publicado: (2022)

CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer
por: Adib, Elio, et al.
Publicado: (2021)

Yield and Utility of Germline Testing Following Tumor Sequencing in Patients With Cancer
por: Lincoln, Stephen E., et al.
Publicado: (2020)

Prevalence of Germline Findings Among Tumors From Cancer Types Lacking Hereditary Testing Guidelines
por: Yap, Timothy A., et al.
Publicado: (2022)

Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma
por: Nassar, Amin H., et al.
Publicado: (2019)

Universal Genetic Testing vs. Guideline-Directed Testing for Hereditary Cancer Syndromes Among Traditionally Underrepresented Patients in a Community Oncology Program
por: Jones, Jeremy C, et al.
Publicado: (2023)

An optimized protocol for evaluating pathogenicity of VHL germline variants in patients suspected with von Hippel-Lindau syndrome: Using somatic genome to inform the role of germline variants
por: Koeller, Diane R., et al.
Publicado: (2022)

Underdiagnosis of Hereditary Colorectal Cancers Among Medicare Patients: Genetic Testing Criteria for Lynch Syndrome Miss the Mark
por: Muller, Charles, et al.
Publicado: (2021)

An integrated somatic and germline approach to aid interpretation of germline variants of uncertain significance in cancer susceptibility genes
por: Schwartz, Alison, et al.
Publicado: (2022)

Rare hereditary cause of chronic pancreatitis in a young male: SPINK1 mutation
por: Patel, Janaki, et al.
Publicado: (2017)

Comparison of Germline Genetic Testing Before and After a Medical Policy Covering Universal Testing Among Patients With Colorectal Cancer
por: Moretz, Chad, et al.
Publicado: (2022)

Hereditary Aspects of Colorectal Cancer: Mismatch Repair Genes Drive Lynch Syndrome
por: Hampel, Heather, et al.
Publicado: (2018)

Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake
por: Ramsey, Mitchell L., et al.
Publicado: (2022)

Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception
por: Bychkovsky, Brittany L., et al.
Publicado: (2023)

Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interception
por: Bychkovsky, Brittany L., et al.
Publicado: (2023)

Case report expanding the germline AXIN2- related phenotype to include olfactory neuroblastoma and gastric adenoma
por: Macklin- Mantia, Sarah K., et al.
Publicado: (2020)

The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility
por: Liu, Mengyuan, et al.
Publicado: (2020)

Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families
por: Määttä, Kirsi M., et al.
Publicado: (2017)

Hereditary diffuse gastric cancer: association with lobular breast cancer
por: Schrader, Kasmintan A., et al.
Publicado: (2007)

Germline CDH1 deletions in hereditary diffuse gastric cancer families
por: Oliveira, Carla, et al.
Publicado: (2009)

Identification of Germline Variants in Patients with Hereditary Cancer Syndromes in Northeast Mexico
por: Pérez-Ibave, Diana Cristina, et al.
Publicado: (2023)

Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
por: Beitsch, Peter D., et al.
Publicado: (2019)

Advanced adenomas may be a red flag for hereditary cancer syndromes
por: Patel, Swati G., et al.
Publicado: (2021)

Germline pathogenic variants in cancer risk genes among patients with thyroid cancer and suspected predisposition
por: Kamihara, Junne, et al.
Publicado: (2022)

The Impact of Proband Indication for Genetic Testing on the Uptake of Cascade Testing Among Relatives
por: Schmidlen, Tara J., et al.
Publicado: (2022)

Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian Cancer
por: Desai, Neelam V., et al.
Publicado: (2023)

Complex Landscape of Germline Variants in Brazilian Patients With Hereditary and Early Onset Breast Cancer
por: Torrezan, Giovana T., et al.
Publicado: (2018)

Criteria of the German Consortium for Hereditary Breast and Ovarian Cancer for the Classification of Germline Sequence Variants in Risk Genes for Hereditary Breast and Ovarian Cancer
por: Wappenschmidt, Barbara, et al.
Publicado: (2020)

Universal Germline-Genetic Testing for Breast Cancer: Implementation in a Rural Practice and Impact on Shared Decision-Making
por: Shelton, Charles, et al.
Publicado: (2023)

Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes
por: Turin, Christie G, et al.
Publicado: (2022)

Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer
por: Whitworth, Pat W., et al.
Publicado: (2022)

Germline mutational spectrum in Armenian breast cancer patients suspected of hereditary breast and ovarian cancer
por: Moradian, Mike M., et al.
Publicado: (2021)

Impact of genetic testing on risk-reducing behavior in women at risk for hereditary gynecologic cancer syndromes
por: Yurgelun, Matthew B, et al.
Publicado: (2010)

Time Trends in the Diagnosis of Colorectal Cancer With Obstruction, Perforation, and Emergency Admission After the Introduction of Population-Based Organized Screening
por: Decker, Kathleen M., et al.
Publicado: (2020)

Comprehensive Analysis of Germline Variants in Mexican Patients with Hereditary Breast and Ovarian Cancer Susceptibility
por: Quezada Urban, Rosalía, et al.
Publicado: (2018)

Identification of hereditary breast and ovarian cancer germline variants in Granada (Spain): NGS perspective
por: Molina-Zayas, María, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7qo9qc35mrk0mvje4qir0mi3rg